We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Verseon (DI) | LSE:VSN | London | Ordinary Share | COM USD0.001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 74.00 | 70.00 | 78.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/9/2018 13:45 | Verseon (VSN) News Out Just Now | danieldanj | |
20/8/2015 15:04 | This one is too long term for me to consider as a direct holding. Its going to be a while before it gets anything into P1. Perhaps they could get some sort of licensing deal with a major to create some candidates for them. I'd hope they dont want to run the trials themselves | dr biotech | |
20/8/2015 10:22 | News today, and I guess more to come. I wonder why others have missed this great investment for the future!! The only way is up and up..... I like this one | rocketblast | |
19/8/2015 15:19 | i agree this one should do very well and still very cheap compared with initial price, guess we are waiting for news as I am sure Woodford is no fool and would have selected after doing a thorough review and research.....interes | rocketblast | |
11/8/2015 09:16 | This is one of the largest holding in the woodford patient capital as released today. Could generate some interest. | dr biotech | |
25/6/2015 11:24 | So Woodford increases his stake here! He ain't no mug chaps and I have heard a few other saying that this has real potential. Might be worth having a closer look | rikivilla | |
28/5/2015 00:23 | NW has an interest | bscuit |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions